COVID-19 Impact on Global Nasal Polyps Diagnosis and Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C83764688C04EN
QYResearch

Abstracts

This report focuses on the global Nasal Polyps Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nasal Polyps Diagnosis and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• OptiNose US
• Regeneron Pharmaceuticals
• Merck
• Pfizer
• F. Hoffmann La-Roche
• Intersect ENT
• GlaxoSmithKline
• Sanofi
• Novartis

Market segment by Type, the product can be split into

• Pharmacological Therapies
• Surgeries

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Nasal Polyps Diagnosis and Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Nasal Polyps Diagnosis and Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nasal Polyps Diagnosis and Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nasal Polyps Diagnosis and Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Nasal Polyps Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Pharmacological Therapies
  1.4.3 Surgeries
1.5 Market by Application
  1.5.1 Global Nasal Polyps Diagnosis and Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Specialty Clinics
1.6 Coronavirus Disease 2019 (Covid-19): Nasal Polyps Diagnosis and Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Nasal Polyps Diagnosis and Treatment Industry
    1.6.1.1 Nasal Polyps Diagnosis and Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Nasal Polyps Diagnosis and Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Nasal Polyps Diagnosis and Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Nasal Polyps Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Nasal Polyps Diagnosis and Treatment Growth Trends by Regions
  2.2.1 Nasal Polyps Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Nasal Polyps Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Nasal Polyps Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Nasal Polyps Diagnosis and Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Nasal Polyps Diagnosis and Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Nasal Polyps Diagnosis and Treatment Players by Market Size
  3.1.1 Global Top Nasal Polyps Diagnosis and Treatment Players by Revenue (2015-2020)
  3.1.2 Global Nasal Polyps Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Nasal Polyps Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nasal Polyps Diagnosis and Treatment Market Concentration Ratio
  3.2.1 Global Nasal Polyps Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Nasal Polyps Diagnosis and Treatment Revenue in 2019
3.3 Nasal Polyps Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Nasal Polyps Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Nasal Polyps Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Nasal Polyps Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Nasal Polyps Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)

5 NASAL POLYPS DIAGNOSIS AND TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Nasal Polyps Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
6.2 Nasal Polyps Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
7.2 Nasal Polyps Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
8.2 Nasal Polyps Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
9.2 Nasal Polyps Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
10.2 Nasal Polyps Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
11.2 Nasal Polyps Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Nasal Polyps Diagnosis and Treatment Market Size (2015-2020)
12.2 Nasal Polyps Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 OptiNose US
  13.1.1 OptiNose US Company Details
  13.1.2 OptiNose US Business Overview and Its Total Revenue
  13.1.3 OptiNose US Nasal Polyps Diagnosis and Treatment Introduction
  13.1.4 OptiNose US Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020))
  13.1.5 OptiNose US Recent Development
13.2 Regeneron Pharmaceuticals
  13.2.1 Regeneron Pharmaceuticals Company Details
  13.2.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Regeneron Pharmaceuticals Nasal Polyps Diagnosis and Treatment Introduction
  13.2.4 Regeneron Pharmaceuticals Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.2.5 Regeneron Pharmaceuticals Recent Development
13.3 Merck
  13.3.1 Merck Company Details
  13.3.2 Merck Business Overview and Its Total Revenue
  13.3.3 Merck Nasal Polyps Diagnosis and Treatment Introduction
  13.3.4 Merck Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.3.5 Merck Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Nasal Polyps Diagnosis and Treatment Introduction
  13.4.4 Pfizer Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 F. Hoffmann La-Roche
  13.5.1 F. Hoffmann La-Roche Company Details
  13.5.2 F. Hoffmann La-Roche Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann La-Roche Nasal Polyps Diagnosis and Treatment Introduction
  13.5.4 F. Hoffmann La-Roche Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.5.5 F. Hoffmann La-Roche Recent Development
13.6 Intersect ENT
  13.6.1 Intersect ENT Company Details
  13.6.2 Intersect ENT Business Overview and Its Total Revenue
  13.6.3 Intersect ENT Nasal Polyps Diagnosis and Treatment Introduction
  13.6.4 Intersect ENT Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.6.5 Intersect ENT Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.7.3 GlaxoSmithKline Nasal Polyps Diagnosis and Treatment Introduction
  13.7.4 GlaxoSmithKline Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Nasal Polyps Diagnosis and Treatment Introduction
  13.8.4 Sanofi Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.8.5 Sanofi Recent Development
13.9 Novartis
  13.9.1 Novartis Company Details
  13.9.2 Novartis Business Overview and Its Total Revenue
  13.9.3 Novartis Nasal Polyps Diagnosis and Treatment Introduction
  13.9.4 Novartis Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
  13.9.5 Novartis Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Nasal Polyps Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Nasal Polyps Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Nasal Polyps Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nasal Polyps Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacological Therapies
Table 6. Key Players of Surgeries
Table 7. COVID-19 Impact Global Market: (Four Nasal Polyps Diagnosis and Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Nasal Polyps Diagnosis and Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Nasal Polyps Diagnosis and Treatment Players to Combat Covid-19 Impact
Table 12. Global Nasal Polyps Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Nasal Polyps Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Nasal Polyps Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Nasal Polyps Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 16. Global Nasal Polyps Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Nasal Polyps Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Nasal Polyps Diagnosis and Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Nasal Polyps Diagnosis and Treatment Players
Table 23. Global Nasal Polyps Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Nasal Polyps Diagnosis and Treatment Market Share by Players (2015-2020)
Table 25. Global Top Nasal Polyps Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Diagnosis and Treatment as of 2019)
Table 26. Global Nasal Polyps Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Nasal Polyps Diagnosis and Treatment Product Solution and Service
Table 29. Date of Enter into Nasal Polyps Diagnosis and Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Nasal Polyps Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 33. Global Nasal Polyps Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Nasal Polyps Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 35. Global Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Nasal Polyps Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 39. North America Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 41. North America Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 45. Europe Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 47. Europe Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 51. China Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 53. China Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 57. Japan Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 59. Japan Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 63. Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 69. India Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 71. India Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Nasal Polyps Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Nasal Polyps Diagnosis and Treatment Market Share (2019-2020)
Table 75. Central & South America Nasal Polyps Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Nasal Polyps Diagnosis and Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Nasal Polyps Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Nasal Polyps Diagnosis and Treatment Market Share by Application (2015-2020)
Table 79. OptiNose US Company Details
Table 80. OptiNose US Business Overview
Table 81. OptiNose US Product
Table 82. OptiNose US Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 83. OptiNose US Recent Development
Table 84. Regeneron Pharmaceuticals Company Details
Table 85. Regeneron Pharmaceuticals Business Overview
Table 86. Regeneron Pharmaceuticals Product
Table 87. Regeneron Pharmaceuticals Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 88. Regeneron Pharmaceuticals Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. F. Hoffmann La-Roche Company Details
Table 100. F. Hoffmann La-Roche Business Overview
Table 101. F. Hoffmann La-Roche Product
Table 102. F. Hoffmann La-Roche Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 103. F. Hoffmann La-Roche Recent Development
Table 104. Intersect ENT Company Details
Table 105. Intersect ENT Business Overview
Table 106. Intersect ENT Product
Table 107. Intersect ENT Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 108. Intersect ENT Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 113. GlaxoSmithKline Recent Development
Table 114. Sanofi Business Overview
Table 115. Sanofi Product
Table 116. Sanofi Company Details
Table 117. Sanofi Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 118. Sanofi Recent Development
Table 119. Novartis Company Details
Table 120. Novartis Business Overview
Table 121. Novartis Product
Table 122. Novartis Revenue in Nasal Polyps Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 123. Novartis Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Nasal Polyps Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Pharmacological Therapies Features
Figure 3. Surgeries Features
Figure 4. Global Nasal Polyps Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Nasal Polyps Diagnosis and Treatment Report Years Considered
Figure 9. Global Nasal Polyps Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Nasal Polyps Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Nasal Polyps Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Nasal Polyps Diagnosis and Treatment Market Share by Players in 2019
Figure 14. Global Top Nasal Polyps Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Polyps Diagnosis and Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Nasal Polyps Diagnosis and Treatment Revenue in 2019
Figure 16. North America Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Nasal Polyps Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. OptiNose US Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. OptiNose US Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 25. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Regeneron Pharmaceuticals Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 31. F. Hoffmann La-Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. F. Hoffmann La-Roche Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 33. Intersect ENT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Intersect ENT Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 35. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GlaxoSmithKline Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 39. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Novartis Revenue Growth Rate in Nasal Polyps Diagnosis and Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed